2 months Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates Zacks
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
X